Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × NIH × Hyperthyroidism × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 274 Neoplasms 245 Prostatic Neoplasms 167 Lymphoma 161 Precursor Cell Lymphoblastic Leukemia-Lymphoma 159 Melanoma 146 Leukemia 143 Leukemia, Lymphocytic, Chronic, B-Cell 140 Lymphoma, Non-Hodgkin 132 Leukemia, Myeloid, Acute 128 Brain Neoplasms 128 Carcinoma, Non-Small-Cell Lung 124 Colonic Neoplasms 120 Lymphoma, Large B-Cell, Diffuse 114 Lymphoma, Follicular 106 Burkitt Lymphoma 104 Ovarian Neoplasms 103 Lung Neoplasms 103 Unspecified Adult Solid Tumor, Protocol Specific 101 Lymphoma, Mantle-Cell 100 Glioblastoma 100 Rectal Neoplasms 97 Sarcoma 94 Gliosarcoma 88 Carcinoma, Renal Cell 88 Carcinoma, Ovarian Epithelial 86 Astrocytoma 84 Colorectal Neoplasms 83 Multiple Myeloma 82 Hodgkin Disease 82

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02989103 2020-10-29

Hyperthyroid Follow-Up Study

National Institutes of Health Clinical Center (CC)

35,593 enrolled

Hyperthyroidism, Thyroid Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡